SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
46.98
-0.01 (-0.02%)
At close: Jun 27, 2025, 4:00 PM
46.99
+0.01 (0.02%)
After-hours: Jun 27, 2025, 7:46 PM EDT
SpringWorks Therapeutics Employees
SpringWorks Therapeutics had 368 employees as of December 31, 2024. The number of employees increased by 63 or 20.66% compared to the previous year.
Employees
368
Change (1Y)
63
Growth (1Y)
20.66%
Revenue / Employee
$596,929
Profits / Employee
-$690,035
Market Cap
3.54B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SWTX News
- 8 days ago - SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors - GlobeNewsWire
- 24 days ago - SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc. - SWTX - Business Wire
- 5 weeks ago - SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN - GlobeNewsWire
- 2 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of SpringWorks Therapeutics, Inc. - PRNewsWire
- 2 months ago - Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B - Investopedia
- 2 months ago - Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal - WSJ
- 2 months ago - Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks - Reuters
- 2 months ago - Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business - GlobeNewsWire